Antithrombotic Strategy in Cerebral Venous Thrombosis: Differences Between Neurologists and Haematologists in a Canadian Survey (P6.007)

Conclusions: In this cohort, there are differences between neurologists and hematologists with regards to initial choice of anticoagulant. It is possible that more complex presenting cases of CVT with concurrent venous infarction, hemorrhage or seizure may present to neurologists as compared to hematologists. Thus, an initial preference for UFH may reflect a desire for a reversible agent with a short half-life in the event of bleeding complications in an unstable patient. Our study is limited by response bias, though our response rate of 28[percnt] is comparable to other contemporary web-based physician surveys. The majority of were from academic centres and responses may not reflect patterns of practice in the community.Disclosure: Dr. Alshimemeri has nothing to disclose. Dr. Camden has nothing to disclose. Dr. Lui has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Field has nothing to disclose.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Alshimemeri, S., Camden, M.-C., Lui, G., Lee, A., Field, T. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research